{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:12:28Z","timestamp":1792757548760,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejogrb.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T03:12:24Z","timestamp":1628392344000},"page":"7-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1\/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2973-6495","authenticated-orcid":false,"given":"Victoria","family":"Kershaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"India","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4046-5940","authenticated-orcid":false,"given":"Lynda","family":"Wyld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4519-6903","authenticated-orcid":false,"given":"Swati","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2021.08.001_b0005","unstructured":"United States Cancer Statistics Working Group (2014). United States Cancer Statistics 1999-2011 Incidence and Mortality Web-based Report. Atlanta, USA, 2014. www.cdc.gov\/cancer\/uscs. [accessed 17\/2\/21]."},{"key":"10.1016\/j.ejogrb.2021.08.001_b0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2015.12.004","article-title":"The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy","volume":"85","author":"Tucker","year":"2016","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.08.001_b0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021. NCCN Clinical Practice Guidelines in Oncology","volume":"1","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2018.05.011","article-title":"The Hereditary Ovarian Cancer Clinical Study Group. Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation","volume":"150","author":"Kotsopoulos","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0035","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.2018.78.4777","article-title":"Cancer Risks for PMS2 -Associated Lynch Syndrome","volume":"36","author":"ten Broeke","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.08.001_b0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/13697137.2017.1285879","article-title":"Impact of risk-reducing salpingo-oophorectomy in premenopausal women","volume":"20","author":"Vermeulen","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejca.2017.07.018","article-title":"Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study","volume":"84","author":"Vermeulen","year":"2017","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.08.001_b0055","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ygyno.2018.03.060","article-title":"Characteristics of Lynch syndrome associated ovarian cancer","volume":"150","author":"Woolderink","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2021.08.001_b0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/ijgc-00009577-200602001-00009","article-title":"Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study","volume":"16","author":"Gaarenstroom","year":"2006","journal-title":"Int J Gynecol Cancer Supplement"},{"issue":"24","key":"10.1016\/j.ejogrb.2021.08.001_b0065","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1200\/JCO.2005.05.097","article-title":"Screening for Familial Ovarian Cancer: Failure of Current Protocols to Detect Ovarian Cancer at an Early Stage According to the International Federation of Gynecology and Obstetrics System","volume":"23","author":"Stirling","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2015.11.016","article-title":"Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy","volume":"140","author":"Johansen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0075","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk mortality","author":"Domcheck","year":"2010","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.ejogrb.2021.08.001_b0080","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ejogrb.2021.08.001_b0085","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejogrb.2021.08.001_b0090","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.08.001_b0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.2006.07.4922","article-title":"Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1\/2 Mutation Carriers","volume":"25","author":"Madalinska","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2018.10.040","article-title":"Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation","volume":"152","author":"Hall","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/GME.0000000000001422","article-title":"Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women","volume":"27","author":"Hickey","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0110","unstructured":"American Psychiatric Association. Sexual Dysfunction. Diagnostic and Statistical Manual of Mental Disorders (5th ed) 2013. https:\/\/dsm.psychiatryonline.org. [accessed 17\/2\/21]."},{"key":"10.1016\/j.ejogrb.2021.08.001_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PPO.0b013e31819585f1","article-title":"Unraveling the Next Chapter: Sexual development, body image, and sexual functioning in female BRCA carriers","volume":"15","author":"Matloff","year":"2009","journal-title":"Cancer J"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ygyno.2015.11.002","article-title":"Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy","volume":"140","author":"Tucker","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jsm.12713","article-title":"Addressing Sexual Dysfunction After Risk-Reducing Salpingo-Oophorectomy: Effects of a Brief, Psychosexual Intervention","volume":"12","author":"Bober","year":"2015","journal-title":"J Sex Medicine"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10689-010-9384-z","article-title":"What I wish I\u2019d known before surgery: BRCA carriers\u2019 perspectives after bilateral salipingo-oophorectomy","volume":"10","author":"Campfield Bonadies","year":"2011","journal-title":"Fam Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.08.001_b0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10689-011-9504-4","article-title":"kConFab Psychosocial Group on behalf of the kConFab Investigators. Looking different, feeling different: women\u2019s reactions to risk-reducing breast and ovarian surgery","volume":"11","author":"Hallowell","year":"2012","journal-title":"Fam Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.08.001_b0140","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/IGC.0000000000000943","article-title":"Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy","volume":"27","author":"Tucker","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.08.001_b0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.maturitas.2011.08.001","article-title":"Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review","volume":"70","author":"Finch","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0150","first-page":"2008","article-title":"Meta-analysis of observational studies in epidemiology","volume":"15","author":"Stroup","year":"2019","journal-title":"A proposal for reporting. JAMA"},{"issue":"7","key":"10.1016\/j.ejogrb.2021.08.001_b0155","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0160","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2019","journal-title":"Ottawa Hospital Res Inst"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.08.001_b0165","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/13697130902780846","article-title":"Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy","volume":"12","author":"Benshushan","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/GME.0000000000001176","article-title":"Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy","volume":"26","author":"Chan","year":"2019","journal-title":"Menopause"},{"issue":"15 Supplement 1","key":"10.1016\/j.ejogrb.2021.08.001_b0175","article-title":"Quality of life in BRCA1 and BRCA2 mutation carriers (B1\/2) following risk-reducing salpingo-oophorectomy (RRS0). American Society of","volume":"35","author":"Domchek","year":"2014","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1021119405814","article-title":"Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer","volume":"1","author":"Elit","year":"2001","journal-title":"Fam Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.08.001_b0185","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ygyno.2008.11.039","article-title":"A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer","volume":"112","author":"Fang","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.08.001_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/pon.512","article-title":"Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer","volume":"10","author":"Fry","year":"2001","journal-title":"Psycho Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10689-014-9759-7","article-title":"Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and\/or ovarian cancer","volume":"14","author":"Heiniger","year":"2015","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0200","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdw575.006","article-title":"Quality of life after risk-reducing salpingo-oophorectomy in BRCA carrier","author":"Jang","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.08.001_b0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/0167482X.2014.899577","article-title":"Relationship satisfaction predicts sexual activity following risk-reducing salpingo-oophorectomy","volume":"35","author":"Lorenz","year":"2014","journal-title":"J Psychosom Obst Gyn"},{"issue":"28","key":"10.1016\/j.ejogrb.2021.08.001_b0210","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian Cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.08.001_b0215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10689-012-9527-5","article-title":"The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause","volume":"11","author":"Pezaro","year":"2012","journal-title":"Fam Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.08.001_b0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/pon.5253","article-title":"Sexual function, menopausal symptoms, depression and cancer worry in women with BRCA mutations","volume":"29","author":"Powell","year":"2020","journal-title":"Psycho Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.08.001_b0225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0090-8258(03)00072-6","article-title":"Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy","volume":"89","author":"Robson","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2021.08.001_b0230","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1634\/theoncologist.2010-0336","article-title":"Factors Associated with Altered Long-Term Well-Being After Prophylactic Salpingo-Oophorectomy Among Women at Increased Hereditary Risk for Breast and Ovarian Cancer","volume":"16","author":"Touboul","year":"2011","journal-title":"Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2021.08.001_b0235","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1002\/cncr.25820","article-title":"Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma","volume":"117","author":"Westin","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0240","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.282.20.1934","article-title":"Hysterectomy and Sexual Functioning","volume":"282","author":"Rhodes","year":"1999","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.ejogrb.2021.08.001_b0245","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pon.991","article-title":"Body image and sexual problems in young women with breast cancer","volume":"15","author":"Fobair","year":"2006","journal-title":"Psycho Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0250","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1743-6109.2010.02034.x","article-title":"Sexual Function after Breast Cancer","volume":"8","author":"Panjari","year":"2011","journal-title":"J Sex Med"},{"issue":"15","key":"10.1016\/j.ejogrb.2021.08.001_b0255","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0959-8049(00)00197-0","article-title":"Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction","volume":"36","author":"Al-Ghazal","year":"2000","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.08.001_b0260","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.breast.2004.10.008","article-title":"Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective study","volume":"14","author":"Elder","year":"2005","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.08.001_b0265","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00003081-197612000-00005","article-title":"Hormonal dynamics associated with the menopause","volume":"19","author":"Judd","year":"1976","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0090-8258(91)90083-H","article-title":"Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause","volume":"1","author":"Hughes","year":"1991","journal-title":"Gynecol Oncol"},{"issue":"22","key":"10.1016\/j.ejogrb.2021.08.001_b0275","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-Oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0280","unstructured":"National Institute for Health and Care Excellence (NICE). Menopause: diagnosis and management. NICE guidelines 2019. https:\/\/www.nice.org.uk\/guidance\/ng23. [accessed 1\/8\/21]."},{"issue":"8","key":"10.1016\/j.ejogrb.2021.08.001_b0285","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/jwh.2006.15.898","article-title":"Estrogen and Androgen Hormone Therapy and Well-Being in Surgically Postmenopausal Women","volume":"15","author":"Kotz","year":"2006","journal-title":"J Women\u2019s Health"},{"issue":"10","key":"10.1016\/j.ejogrb.2021.08.001_b0290","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM200009073431002","article-title":"Transdermal Testosterone Treatment in Women with Impaired Sexual Function after Oophorectomy","volume":"343","author":"Shifren","year":"2000","journal-title":"New Engl J Medicine"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinternmed.2008.507","article-title":"Influence of Estrogen Plus Testosterone Supplementation on Breast Cancer","volume":"169","author":"Ness","year":"2009","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0300","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2018.12.014","article-title":"Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits","volume":"153","author":"Gordhandas","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"31","key":"10.1016\/j.ejogrb.2021.08.001_b0305","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.ejogrb.2021.08.001_b0310","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":"The Hereditary Breast Cancer Clinical Study Group. Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers","volume":"100","author":"Eisen","year":"2008","journal-title":"J National Cancer Inst"},{"issue":"8","key":"10.1016\/j.ejogrb.2021.08.001_b0315","first-page":"1059","article-title":"The Hereditary Breast Cancer Clinical Study Group. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"Oncol"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0320","unstructured":"Royal College of Obstetricians & Gynaecologists (RCOG). Alternatives to HRT for the Management of Symptoms of the Menopause. Scientific Impact Paper No. 6. 2010. https:\/\/www\/rcog.org.uk\/globalassets\/documents\/guidelines\/scientific-impact-papers\/sip_6.pdf. [accessed 1\/8\/21]."},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.001_b0325","article-title":"Mindfulness-Based Stress Reduction (MBSR) or Psychoeducation for the Reduction of Menopausal Symptoms: A Randomized, Controlled Clinical Trial","volume":"8","author":"Wong","year":"2018","journal-title":"Sci Rep UK"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0330","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/IGC.0000000000000750","article-title":"Discussing Sexuality With Women Considering Risk-Reducing Salpingo-oophorectomy","volume":"26","author":"Tucker","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.08.001_b0335","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1701-2163(16)35160-X","article-title":"Risk-Reducing Bilateral Salpingo-Oophorectomy and Sexual Health: A Qualitative Study","volume":"34","author":"Brotto","year":"2012","journal-title":"J Obstetrics Gynaecol Can"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.08.001_b0340","doi-asserted-by":"crossref","first-page":"e556","DOI":"10.1016\/j.clbc.2019.04.007","article-title":"The Impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: A systematic review and meta-analysis","volume":"19","author":"Jha","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ejogrb.2021.08.001_b0345","unstructured":"Royal College of Obstetricians & Gynaecologists (RCOG). The Distal Fallopian Tube as the Origin of Non-Uterine Pelvic High-Grade Serous Carcinomas. Scientific Impact Paper No. 44. 2014. https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/scientific-impact-papers\/sip44hgscs.pdf. [accessed 17\/2\/21]."}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:53:19Z","timestamp":1759557199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521004012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":69,"alternative-id":["S0301211521004012"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.08.001","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1\/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}